Bionano Genomics Inc (BNGO)
0.245
-0.01
(-4.26%)
USD |
NASDAQ |
Nov 15, 16:00
0.245
0.00 (0.00%)
After-Hours: 18:21
Bionano Genomics Net Income (TTM): -204.10M for June 30, 2024
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2024 | -204.10M |
| March 31, 2024 | -226.79M |
| December 31, 2023 | -232.49M |
| September 30, 2023 | -227.28M |
| June 30, 2023 | -146.52M |
| March 31, 2023 | -139.77M |
| December 31, 2022 | -132.60M |
| September 30, 2022 | -116.87M |
| June 30, 2022 | -105.81M |
| March 31, 2022 | -92.44M |
| December 31, 2021 | -72.44M |
| September 30, 2021 | -61.22M |
| June 30, 2021 | -51.26M |
| March 31, 2021 | -40.54M |
| Date | Value |
|---|---|
| December 31, 2020 | -41.11M |
| September 30, 2020 | -37.28M |
| June 30, 2020 | -32.88M |
| March 31, 2020 | -32.47M |
| December 31, 2019 | -29.82M |
| September 30, 2019 | -28.33M |
| June 30, 2019 | -26.85M |
| March 31, 2019 | -22.50M |
| December 31, 2018 | -18.50M |
| September 30, 2018 | -18.00M |
| June 30, 2018 | -18.16M |
| March 31, 2018 | -21.53M |
| December 31, 2017 | -23.37M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (TTM) Range, Past 5 Years
-232.49M
Minimum
Dec 2023
-29.82M
Maximum
Dec 2019
-106.51M
Average
-92.44M
Median
Mar 2022
Net Income (TTM) Benchmarks
| Revvity Inc | 254.30M |
| Bruker Corp | 304.90M |
| Azenta Inc | -155.81M |
| Harvard Bioscience Inc | -14.24M |
| Akoya Biosciences Inc | -60.35M |